| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |